BeStock  
Stocks › Biotechnology › AGIO

Agios Pharmaceuticals AGIO

US equityMarket cap rank #2807Biotechnology
$27.60 −$1.16 (-4.03%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $27.60 0.00%
Open$28.01
Prev close$28.76
Day range$27.43 – $29.14
Volume776.2K
Market cap$1.65B
P/E (TTM)–
Dividend yield–

Valuation

Multiples measured against the stock's own five-year history

Price / earnings-5.0x
CheapRich

Around its usual level · 48th percentile, 5-year average -3.4x

Price / book1.9x
CheapRich

Above its usual level · 79th percentile, 5-year average 1.7x

#3005 of 5330 stocks by PB (1 = cheapest)

Price / sales13.4x
CheapRich

Near the bottom of its 5-year range · 10th percentile, 5-year average 136.6x

#4613 of 5155 stocks by PS (1 = cheapest)

P/E over five years

-13x-7x0x6xOct '21Apr '24Nov '26

Dashed line is the 5-year average; the shaded band is one standard deviation either side.

Morningstar fair value estimate

Fair value$35.77
Price vs. fair value-22.8%Trading below the estimate
Star rating★★★☆☆
Economic moatNone
UncertaintyVery High
MultipleCurrentForward5y averagePercentile vs. own historyIndustry rank
PB 1.93 – 1.66 79% (pricier than usual) #3005 of 5330 (1 = cheapest)
PE -5.01 -8.27 -3.38 48% (cheaper than usual) –
PS 13.41 6.18 136.55 10% (cheaper than usual) #4613 of 5155 (1 = cheapest)

Percentile is against this stock’s own 5-year valuation range: higher means it’s trading rich relative to its own history, lower means cheap relative to its own history — it is not a comparison against other companies. Forward multiples use consensus estimates for the next twelve months; a forward multiple below the current one usually signals analysts expect earnings to grow.

Discussion

No comments yet — be the first to weigh in on AGIO.

Sign in to join the discussion.

Scroll to Top